Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks Endpoints News‘Too Good to Be True:' A Chinese Study on Timing Cancer Therapy Is Retracted The New York TimesNature retracts provocative PD-1 study that tied lung cancer survival to treatment timing Fierce PharmaNature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation Applied Clinical Trials Online
